Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | HPGD | P15428 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 4/20 | 0.39 |
| ▸ | AKR1C2 | P52895 | 4/20 | 0.39 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29439072 | 1.00 | ALDH1A1 (0.44) | ALDH1A1HPGDKMT2AHSD17B10CYP1A2 | |
| SCHEMBL15881404 | 0.91 | ALDH1A1 (0.38) | ALDH1A1HPGDKMT2AHSD17B10CYP1A2 | |
| SCHEMBL3485158 | 0.89 | KMT2A (0.49) | ALDH1A1HPGDKMT2AHSD17B10CYP1A2 | |
| Succinimide SCHEMBL28533922 | 0.88 | ALDH1A1 (0.36) | ALDH1A1HPGDKMT2AHSD17B10CYP1A2 | |
| SCHEMBL16428359 | 0.88 | ALDH1A1 (0.42) | ALDH1A1HPGDKMT2AHSD17B10CYP1A2 | |
| SCHEMBL10905515 | 0.88 | ALDH1A1 (0.43) | ALDH1A1HPGDKMT2AHSD17B10CYP1A2 | |
| SCHEMBL5352784 | 0.87 | ALDH1A1 (0.36) | ALDH1A1HPGDKMT2AHSD17B10CYP1A2 | |
| SCHEMBL15389891 | 0.86 | ALDH1A1 (0.42) | ALDH1A1HPGDKMT2AHSD17B10CYP1A2 | |
| SCHEMBL9820389 | 0.85 | KMT2A (0.43) | ALDH1A1HPGDKMT2AHSD17B10CYP1A2 | |
| SCHEMBL29936283 | 0.84 | ALDH1A1 (0.48) | ALDH1A1HPGDKMT2AHSD17B10CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5624 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713340-A2 | COMPOSITIONS AND METHODS FOR PEPTIDE-BASED MODULATORS OF HUMAN PAPILLOMAVIRUS ONCOPROTEIN E6 | Calico Life Sciences LLC (US) | 2026-03-25 | — | — | EP | claimed |
| US-12565653-B2 | ATAXIN3 (ATXN3) RNAi agent compositions and methods of use thereof | ALNYLAM PHARMACEUTICALS, INC. (US) | 2026-03-03 | — | — | US | claimed |
| US-12553053-B2 | Transmembrane serine protease 2 (TMPRSS2) iRNA compositions and methods of use thereof | ALNYLAM PHARMACEUTICALS, INC. (US) | 2026-02-17 | — | — | US | claimed |
| US-12534731-B2 | Alpha-2A adrenergic receptor (ADRA2A) iRNA agent compositions and methods of use thereof | ALNYLAM PHARMACEUTICALS, INC. (US) | 2026-01-27 | — | — | US | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| US-20250353872-A1 | Ligand-Modified Oligonucleotides | NOVO NORDISK A/S (DK) | 2025-11-20 | — | — | US | claimed |
| US-20250283079-A1 | ACTIN-BINDING LIM PROTEIN 3 (ABLIM3) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF | ALNYLAM PHARMACEUTICALS, INC. (US) | 2025-09-11 | — | — | US | claimed |
| US-12391945-B2 | Coronavirus IRNA compositions and methods of use thereof | ALNYLAM PHARMACEUTICALS, INC. (US) | 2025-08-19 | — | — | US | claimed |
| EP-4594492-A1 | MODIFIED DOUBLE-STRANDED RNA AGENTS | Alnylam Pharmaceuticals, Inc. (US) | 2025-08-06 | — | — | EP | claimed |
| CN-120202298-A | DsRNA molecule for inhibiting sod1 gene expression and application thereof | 石药集团中奇制药技术（石家庄）有限公司 | 2025-06-24 | — | — | CN | claimed |
| WO-2005035550-A2 | DUAL PHASE-PNA CONJUGATES FOR THE DELIVERY OF PNA THROUGH THE BLOOD BRAIN BARRIER | KERNEL BIOPHARMA INC. (IL) | 2005-04-21 | — | — | WO | claimed |
| US-20050042601-A1 | Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification | BECTON, DICKINSON AND COMPANY | 2005-02-24 | — | — | US | claimed |
| WO-2004094595-A2 | MODIFIED iRNA AGENTS | ALNYLAM PHARMACEUTICALS INC. (US) | 2004-11-04 | — | — | WO | claimed |
| US-5663030-A | A PHENYL OR NORBORNANE DERIVATIVE AS AN ADDITIVE TO REDUCE HEAT AND ENERGY REQUIRED TO FUSE THE TONER AND TO REDUCE JAMMING OF THE EQUIPMENT | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| EP-0383912-B1 | METHOD AND APPARATUS FOR OPTICALLY MEASURING CONCENTRATION OF MATERIAL | TERUMO CORP (JP) | 1994-11-09 | — | — | EP | claimed |
| EP-0344313-B1 | PROBE FOR MEASURING CONCENTRATION OF DISSOLVED GAS | TERUMO CORP (JP) | 1994-05-11 | — | — | EP | claimed |
| US-5151603-A | Quenching phosphors | TERUMO KABUSHIKI KAISHA (JP) | 1992-09-29 | — | — | US | claimed |
| EP-0344313-A1 | PROBE FOR MEASURING CONCENTRATION OF DISSOLVED GAS | TERUMO KABUSHIKI KAISHA (JP) | 1989-12-06 | — | — | EP | claimed |
| US-4728796-A | Method for ionization of polymers | MEDICAL COLLEGE OF WISCONSIN (US) | 1988-03-01 | — | — | US | claimed |
| US-4126516-A | LIPHOPHILIC FLUORESCENT MATERIAL | CORNING GLASS WORKS (US) | 1978-11-21 | — | — | US | claimed |